A Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients

被引：0
|
作者：
Desai, Nirav K. [1 ]
Harney, Sarah [1 ]
Raza, Roshan [1 ]
Mitchell, Paul D. [2 ]
Jonas, Maureen M. [1 ]
机构：
[1] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA
[2] Boston Childrens Hosp, Clin Res Ctr, Boston, MA USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
674
引用
收藏
页码：527A / 527A
页数：1
相关论文
共 50 条
  • [21] Comparison Between Attenuation Measurement and the Controlled Attenuation Parameter for the Assessment of Hepatic Steatosis Based on MRI Images
    Gotoh, Tatsuya
    Kumada, Takashi
    Ogawa, Sadanobu
    Niwa, Fumihiko
    Toyoda, Hidenori
    Hirooka, Masashi
    Koizumi, Yohei
    Hiasa, Yoichi
    Akita, Tomoyuki
    Tanaka, Junko
    Shimizu, Masahito
    LIVER INTERNATIONAL, 2025, 45 (01)
  • [22] CONTROLLED ATTENUATION PARAMETER FOR THE ASSESSMENT OF ALCOHOLIC HEPATIC STEATOSIS: BIOPSY-CONTROLLED DIAGNOSTIC ACCURACY AND ROLE OF DETOXIFICATION
    Thiele, Maja
    Rausch, Vanessa
    Fluhr, Gabriele
    Piecha, Felix
    Mueller, Johannes
    Straub, Beate
    Lupsor-Platon, Monica
    Ledinghen, Victor
    Seitz, Helmut K.
    Detlefsen, Sonke
    Madsen, Bjorn
    Krag, Aleksander
    Mueller, Sebastian
    ALCOHOL AND ALCOHOLISM, 2017, 52
  • [23] Comparison between Results of Hepatic Transient Elastography (fibroscan®) and Controlled Attenuation Parameter (cap™) versus Liver Biopsy in NAFLD Patients
    Vanni, Denise S.
    Oliveira, Claudia P.
    Mazo, Daniel F.
    Rabelo, Fabiola
    Stefano, Jose Tadeu
    Carrilho, Flair J.
    HEPATOLOGY, 2013, 58 : 523A - 523A
  • [24] Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
    Jung, Kyu Sik
    Kim, Beom Kyung
    Kim, Seung Up
    Chon, Young Eun
    Cheon, Kyung Hyun
    Kim, Sung Bae
    Lee, Sang Hoon
    Ahn, Sung Soo
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Park, Young Nyun
    Han, Kwang-Hyub
    PLOS ONE, 2014, 9 (06):
  • [25] Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis
    Salmi, Andrea
    di Filippo, Luigi
    Ferrari, Clarissa
    Frara, Stefano
    Giustina, Andrea
    ENDOCRINE, 2022, 78 (02) : 262 - 269
  • [26] Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis
    Andrea Salmi
    Luigi di Filippo
    Clarissa Ferrari
    Stefano Frara
    Andrea Giustina
    Endocrine, 2022, 78 : 262 - 269
  • [27] Analysis of liver steatosis analysis and controlled attenuation parameter for grading liver steatosis in patients with chronic hepatitis B
    Ren, Xinping
    Xia, Shujun
    Zhang, Lu
    Li, Ruokun
    Zhou, Wei
    Ji, Ri
    Zhou, Jianqiao
    Tian, Jingyan
    Zhan, Weiwei
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2021, 11 (02) : 571 - 578
  • [28] Liver steatosis assessed by controlled attenuation parameter in patients with primary biliary cholangitis
    Bueti, Francesca
    Franze, Maria Stella
    Pitrone, Concetta
    Caccamo, Gaia
    Cacciola, Irene
    Filomia, Roberto
    Maimone, Sergio
    Raimondo, Giovanni
    Saitta, Carlo
    JOURNAL OF HEPATOLOGY, 2024, 80 : S345 - S345
  • [29] Controlled attenuation parameter for evaluating liver steatosis in type 2 diabetes patients
    Sporea, Ioan
    Mare, Ruxandra
    Lupusoru, Raluca
    Silviu, Nistorescu
    Popescu, Alina
    Sirli, Roxana
    Danila, Mirela
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E784 - E784
  • [30] DIAGNOSTIC PERFORMANCE OF CONTROLLED ATTENUATION PARAMETER FOR HEPATIC STEATOSIS IN PATIENT WITH CHRONIC LIVER DISEASE, RETROSPECTIVELY
    Shin, Sukpyo
    Hwang, Seong Gyu
    Park, Hana
    Lee, Joo Ho
    Kwon, Sung Won
    Rim, Kyu Sung
    Kim, Gwangil
    GASTROENTEROLOGY, 2017, 152 (05) : S1115 - S1115
12345